Mindfulness Based Cognitive Therapy for Psychological Distress in Pregnancy

Depression Clinical Trial

Official title:

A Randomized Controlled Trial of Mindfulness Based Cognitive Therapy for Psychological Distress in Pregnancy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02214732
• Other study ID #: REB13-0860
• Status: Completed
• Phase: N/A
• Start date: August 2014
• Est. completion date: September 2017

Study information

• Verified date: September 2018
• Source: University of Calgary
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Anxiety, stress and depression are common during pregnancy and in the postpartum period. The lack of empirically supported, non-pharmaceutical interventions for psychological distress in pregnancy is a significant gap in the literature, especially given many pregnant women's preference for non-pharmaceutical treatments. This study will evaluate the efficacy of Mindfulness Based Cognitive Therapy (MBCT) program in reducing measures of psychological distress (e.g., symptoms of stress, depression and anxiety) in a group of pregnant women endorsing high levels of distress.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 61
• Est. completion date: September 2017
• Est. primary completion date: April 2017
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Eligible women for this study

• are between 12 and 28 weeks of gestation,

• are experiencing psychological distress (elevated perinatal anxiety, mild depressive symptoms, or high-levels of self-reported stress)

Exclusion Criteria:

• current suicidality

• current substance abuse or dependence

• experience a current major depressive episode

• have been diagnosed with bipolar disorder or other disorders that have a psychotic, dissociative, hallucinatory, or delusional component

• taking prescribed medications that affect sleep or mood

Related Conditions & MeSH terms

• Anxiety
• Depression
• Stress

Intervention

Behavioral:
• Mindfulness Based Cognitive Therapy
The modified MBCT program for pregnant women is an 8-session group intervention that aims to help women change their relationship to the thoughts, feelings, and bodily sensations that can lead to psychological distress. Participants are guided to recognize and disengage from unhelpful mind states characterized by self-perpetuating patterns of ruminative thought. The intervention was modified to address pregnant women's physical and emotional needs, as well as their risk of perinatal mood episodes.

Locations

Country	Name	City	State
Canada	Riley Park Maternity Clinic	Calgary	Alberta
Canada	University Of Calgary	Calgary	Alberta

Sponsors (3)

Lead Sponsor	Collaborator
University of Calgary	Alberta Centre for Child, Family & Community Research, Alberta Family Wellness Initiative

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Edinburgh Postpartum Depression Scale scores from baseline to 3 months follow-up postpartum	Symptoms of depression will be assessed using the 10-item, self-report Edinburgh Postpartum Depression Scale (EPDS). The EPDS has been validated against interview schedules and other self-report instruments.	Baseline (Week 1), Post-Treatment (Week 10), 3 months follow-up postpartum (3 months after the birth of a person's baby)
Secondary	Change in Pregnancy Related Anxiety Measure scores from baseline to post-treatment	The Pregnancy Anxiety Measure, a 10-item instrument will be used to examine the extent to which women are worried about their own and baby's health, labour, delivery and caring their new baby.	Baseline (Week 1), Post-Treatment (Week 10)
Secondary	Change in Perceived Stress Scale (PSS-10) scores from baseline to 3 months	This questionnaire will be used in assessing the perception of stress. The questions are in regards to participant's feelings and thoughts during the previous month. It was designed to be used in community samples. The items are assessing perceived helplessness and self-efficacy.	Baseline (Week 1), Post-Treatment (Week 10), 3 months follow-up postpartum
Secondary	Change in Pittsburgh Sleep Quality Index (PSQI) scores from baseline to 3 months	The PSQI instrument will be used in assessing participant's sleep quality. There are seven components of the PSQI and these are subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications and daytime dysfunction.	Baseline (Week 1), Post-Treatment (Week 10), 3 months follow-up postpartum
Secondary	Change in objective measures of sleep using Wrist Actigraphy from baseline to 3 months	Actigraphy monitoring provides objective information on circadian rhythm amplitude, acrophase, as well as indices of sleep efficiency, sleep latency, total sleep time, and number and frequency of awakenings. The use of actigraphy has been demonstrated sensitive to treatment effects, while being less costly and intrusive than polysomnography.	Baseline (Week 1), Post-Treatment (Week 10), 3 months follow-up postpartum
Secondary	Change in salivary cortisol profile from baseline to 3 months	All samples are assayed for salivary cortisol using a highly sensitive enzyme immunoassay.	Baseline (Week 1), Post-Treatment (Week 10), 3 months follow-up postpartum
Secondary	Change in measures of blood pressure (BP) from baseline to 3 months	BP data will be collected using an automatic, calibrated, oscillometric BP monitor and a BP cuff on the upper part of the dominant arm.	Baseline (Week 1), Post-Treatment (Week 10), 3 months follow-up postpartum
Secondary	Changes in measures of heart rate variability from baseline to 3 months	Measures of heart rate (bpm) will be recorded noninvasively using a HIC-2000 Bio-electric Impedance Cardiograph and the Cardiac Output Program, developed by Bio-Impedance Technology.	Baseline (Week 1), Post-Treatment (Week 10), 3 months follow-up postpartum